NCT00303823View on ClinicalTrials.gov

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2010

Study Completion Date

February 28, 2011

Conditions
Cervical CancerCervical Intraepithelial Neoplasia Grade 1Human Papilloma Virus Infection
Interventions
DRUG

placebo

Given orally

DIETARY_SUPPLEMENT

defined green tea catechin extract

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

85724-5024

Arizona Cancer Center - Tucson, Tucson

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00303823 - Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter